Inventor · disambiguated record
Christopher Oalmann
Also filed as: OALMANN CHRISTOPHER · OALMANN CHRISTOPHER J
11 granted patents·9 pending applications·46 citations·filing 2008–2023
86Inventor score
Files withGLAXOSMITHKLINE LLC7AXIAL THERAPEUTICS INC3SIRTRIS PHARMACEUTICALS INC3FLATLEY DISCOVERY LAB LLC2BEMIS JEAN1
Top patents by PatentIndex Score
20 records- 0195US7893086B2Sirtuin modulating compoundsSIRTRIS PHARMACEUTICALS INC·Filed 2008·Granted Feb 22, 2011·34 cites·23 claims
- 0284US9765075B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Sep 19, 2017·2 cites·4 claims
- 0379US8343997B2Thiazolopyridine sirtuin modulating compoundsSIRTRIS PHARMACEUTICALS INC·Filed 2009·Granted Jan 1, 2013·3 cites·13 claims
- 0476US9834558B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Dec 5, 2017·2 cites·2 claims
- 0572US9326986B2Quinazolinone, quinolone and related analogs as sirtuin modulatorsVU CHI B·Filed 2009·Granted May 3, 2016·1 cites·16 claims
- 0672US8987258B2Chromenone analogs as sirtuin modulatorsOALMANN CHRISTOPHER·Filed 2009·Granted Mar 24, 2015·2 cites·4 claims
- 0768US8268862B2Sirtuin modulating compoundsBEMIS JEAN·Filed 2011·Granted Sep 18, 2012·1 cites·25 claims
- 0868US2024156780A1Tlr2 modulator compounds, pharmaceutical compositions and uses thereofAXIAL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0965US8492401B2Thiazolopyridine sirtuin modulating compoundsSIRTRIS PHARMACEUTICALS·Filed 2012·Granted Jul 23, 2013·1 cites·20 claims
- 1065US2018044338A1Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1164US11951094B2TLR2 modulator compounds, pharmaceutical compositions and uses thereofAXIAL THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·0 cites·18 claims
- 1262US10590135B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2015·Granted Mar 17, 2020·0 cites·11 claims
- 1360US2022402925A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2022·Application pending·0 cites
- 1455US2023055237A1Compounds and methods for the treatment of cystic fibrosisFLATLEY DISCOVERY LAB LLC·Filed 2021·Application pending·0 cites
- 1552US2023131899A1Inhibitors of microbially induced amyloidAXIAL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1649US2018186801A1Substituted bicyclic aza-heterocycles and analogues as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2018·Application pending·0 cites
- 1749US2011009381A1Solubilized thiazolopyridinesSIRTIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1849US2011039847A1Amide derivatives as sirtuin modulatorsSIRTRIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1946US2015148343A1Chromenone analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 2035US9957271B2Substituted bicyclic aza-heterocycles and analogues as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2012·Granted May 1, 2018·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Oalmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →